CJC-1295 (With DAC)

CJC-1295 (With DAC)

Price range: $199.00 through $370.99

CJC-1295 (With DAC) is a premium research-grade synthetic peptide manufactured for laboratory and scientific investigations. Produced to >99% purity, it is supplied exclusively for research involving peptide biology, endocrine signaling, receptor interactions, and molecular studies. Not for human or veterinary use.

Strength
Choose an option
CJC-1295 With DAC Research Peptide | BioWellLab UK
Add to cart
Buy Now

Short Description

CJC-1295 (With DAC) is a premium research-grade synthetic peptide manufactured for laboratory and scientific investigations. Produced to >99% purity, it is supplied exclusively for research involving peptide biology, endocrine signaling, receptor interactions, and molecular studies. Not for human or veterinary use.


Long Description

CJC-1295 (With DAC) Research Peptide

Product Overview

CJC-1295 (With DAC) is a synthetic Growth Hormone Releasing Hormone (GHRH) analogue incorporating a Drug Affinity Complex (DAC), supplied exclusively for laboratory and scientific research. It is commonly investigated in experimental studies involving peptide biology, endocrine signaling, receptor interactions, molecular biology, and experimental pharmacology.

BioWellLab manufactures research-grade CJC-1295 (With DAC) under stringent quality standards with a purity exceeding 99%. Every production batch undergoes comprehensive analytical testing to verify purity, identity, and batch-to-batch consistency before release.

This product is supplied strictly for laboratory and scientific research purposes and is not intended for human consumption or veterinary use.


Research Applications

CJC-1295 (With DAC) is commonly investigated in laboratory studies involving:

  • Peptide biology
  • Endocrine signaling research
  • Growth hormone pathway research
  • Receptor binding studies
  • Molecular biology
  • Cell culture studies
  • Protein interaction research
  • Biotechnology research
  • Experimental pharmacology
  • Preclinical peptide investigations

Product Specifications

Specification Details
Product Name CJC-1295 (With DAC)
SKU CD10
Strength 10mg
CAS Number 863288-34-0
Molecular Formula C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight 3647.12 g/mol
Purity >99%
Appearance White to Off-White Lyophilized Powder
Storage Store at -20°C
Grade Research Grade

Quality Assurance

Every BioWellLab peptide is manufactured under rigorous quality standards and tested using validated analytical techniques, including High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography–Mass Spectrometry (LC-MS). Each production batch is verified for purity, identity, and consistency before release. A Certificate of Analysis (COA) accompanies every batch.


Storage

Store unopened vials at -20°C in a clean, dry laboratory environment. After reconstitution, follow standard laboratory storage procedures and avoid repeated freeze–thaw cycles.


Frequently Asked Questions

What is CJC-1295 (With DAC)?

CJC-1295 (With DAC) is a synthetic GHRH analogue incorporating a Drug Affinity Complex (DAC), supplied exclusively for laboratory and scientific investigations.

What purity does BioWellLab provide?

Every batch is analytically tested to confirm a purity of greater than 99%.

What strength is supplied?

Each vial contains 10mg of research-grade lyophilized peptide.

Is this product intended for human use?

No. This product is supplied strictly for laboratory research and must not be used for human consumption or veterinary applications.


Research Use Only

CJC-1295 (With DAC) supplied by BioWellLab UK is intended exclusively for laboratory, analytical, and scientific research purposes. This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used for human or veterinary applications. It should only be handled by qualified professionals in appropriate laboratory settings.

Additional Information

Strength

5mg, 10mg

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (With DAC)”

Your email address will not be published. Required fields are marked *